(Q50668477)

17 March 2018

title

Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART. (English)

1 reference

17 March 2018

author

John Cleland

5

1 reference

17 March 2018

Klaus K. Witte

1

object named as

K Witte

1 reference

17 March 2018

S Thackray

2

1 reference

17 March 2018

A L Clark

3

1 reference

17 March 2018

M Cooklin

4

1 reference

17 March 2018

publication date

1 December 2000

1 reference

17 March 2018

European Journal of Heart Failure

published in

1 reference

17 March 2018

volume

2

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

455-460

1 reference

17 March 2018

The evidence for beta blockers in heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

Is aspirin safe for patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

What is the optimal medical management of ischemic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Carvedilol for Heart Failure: Clinical Trials in Progress

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Anticoagulant and antiplatelet therapy in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

The LIDO, HOPE, MOXCON and WASH studies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2800%2900127-6

7 January 2021

10.1016/S1388-9842(00)00127-6

Identifiers

DOI

1 reference

17 March 2018

PubMed ID

11113724

1 reference

17 March 2018